As expected, in stage III and IV CRC patients, individuals with high DDX21 and high MCM5 expression had the poorest OS and DFS (Fig. 6J), rather than among all stage or stage I and II (Fig. S6G–J). The gene discussed is DDX21; the disease is colorectal carcinoma.